338 related articles for article (PubMed ID: 24957740)
1. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
Dosi R; Ambaliya A; Joshi H; Patell R
BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24957740
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Sokoro AA; Zivot J; Ariano RE
Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist?
Prakash S; Lodha D; Rawat KS
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34400419
[TBL] [Abstract][Full Text] [Related]
4. A Mixed Presentation of Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a 12-Year-Old Boy.
Ott M; Werneke U
Pediatr Emerg Care; 2019 May; 35(5):e98. PubMed ID: 30964850
[No Abstract] [Full Text] [Related]
5. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
[No Abstract] [Full Text] [Related]
6. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Perry PJ; Wilborn CA
Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing between Neuroleptic Malignant Syndrome and Serotonin Syndrome in Polypharmacy: An Overview with a Case Report.
Debeljak T; Kores Plesničar B
Psychiatr Danub; 2021; 33(Suppl 4):1227-1229. PubMed ID: 35354191
[No Abstract] [Full Text] [Related]
8. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic Malignant Syndrome or Serotonin Syndrome?
Nagamine T
Psychiatr Danub; 2022; 34(3):526-527. PubMed ID: 36256997
[No Abstract] [Full Text] [Related]
10. A Mixed Presentation of Serotonin Syndrome vs Neuroleptic Malignant Syndrome in a 12-Year-Old Boy.
Sun C; Sweet H; Minns AB; Shapiro D; Jenkins W
Pediatr Emerg Care; 2020 Oct; 36(10):e589-e591. PubMed ID: 29698346
[TBL] [Abstract][Full Text] [Related]
11. Hyponatremia, convulsions and neuroleptic malignant syndrome in a male with schizoaffective disorder.
Looi JC; Cubis JC; Saboisky J
Aust N Z J Psychiatry; 1995 Dec; 29(4):683-7. PubMed ID: 8825834
[TBL] [Abstract][Full Text] [Related]
12. Lithium-induced confusional states: nonconvulsive status epilepticus or triphasic encephalopathy?
Kaplan PW; Birbeck G
Epilepsia; 2006 Dec; 47(12):2071-4. PubMed ID: 17201705
[TBL] [Abstract][Full Text] [Related]
13. Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
Crosby D; Peterson J; Carroll BT
Ann Clin Psychiatry; 2013 Feb; 25(1):69-70. PubMed ID: 23376873
[No Abstract] [Full Text] [Related]
14. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
[TBL] [Abstract][Full Text] [Related]
15. Prevention, recognition, and management of serotonin syndrome.
Ables AZ; Nagubilli R
Am Fam Physician; 2010 May; 81(9):1139-42. PubMed ID: 20433130
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
Srivastava A; Borkar HA; Chandak S
Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome and its controversies.
Margetić B; Aukst-Margetić B
Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome due to olanzapine.
Hall KL; Taylor WH; Ware MR
Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis.
Kaufman KR; Levitt MJ; Schiltz JF; Sunderram J
Ann Clin Psychiatry; 2006; 18(3):201-4. PubMed ID: 16923659
[TBL] [Abstract][Full Text] [Related]
20. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol].
Marloth PV; Ladefoged MR; Boesen MS
Ugeskr Laeger; 2022 Nov; 184(45):. PubMed ID: 36345898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
